Hydrochloric Acid → HCID 86635169, compound
Reaction equation
[Cl:1][C:2]1[C:7]([C:8]2[CH:13]=[CH:12][CH:11]=[C:10]([CH3:14])[CH:9]=2)=[C:6]([C@:15]([C@@H:25]2[CH2:30][CH2:29][CH2:28][N:27](C(OC(C)(C)C)=O)[CH2:26]2)([OH:24])[CH2:16][CH2:17][CH2:18][NH:19][C:20]([O:22][CH3:23])=[O:21])[CH:5]=[CH:4][CH:3]=1.Cl>CC#N>[Cl:1][C:2]1[C:7]([C:8]2[CH:13]=[CH:12][CH:11]=[C:10]([CH3:14])[CH:9]=2)=[C:6]([C@@:15]([OH:24])([CH:25]2[CH2:30][CH2:29][CH2:28][NH:27][CH2:26]2)[CH2:16][CH2:17][CH2:18][NH:19][C:20](=[O:21])[O:22][CH3:23])[CH:5]=[CH:4][CH:3]=1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of (R)-tert-butyl 3-((S)-1-(6-chloro-3′-methylbiphenyl-2-yl)-1-hydroxy-4-(methoxycarbonylamino)butyl)piperidine-1-carboxylate (600 mg, 1.13 mg) in CH3CN (18 mL) was added 2N aq HCl (15 mL) and the reaction mixture was vigorously stirred overnight at rt. The solvents were removed in vacuo to give methyl (4S)-4-(6-chloro-3′-methylbiphenyl-2-yl)-4-hydroxy-4-(piperidin-3-yl)butylcarbamate as its hydrochloride salt (500 mg, 95.8%). 1H NMR (400 MHz, CD3OD): 1.00-1.20 (m, 1H), 1.30-1.80 (m, 8H), 1.80-2.00 (m, 2H), 2.40-2.50 (d, 3H), 2.75-2.90 (t, 1H), 2.90-3.05 (m, 3H), 3.05-3.12 (t, 1H), 3.20-3.30 (m, 1H), 3.30-3.40 (m, 1H), 3.60-3.70 (d, 4H), 6.90-6.98 (d, 1H), 7.00-7.12 (m, 1H), 7.25-7.50 (m, 4H), 7.75-7.85 (d, 1H); MS (E/Z): 431 (M+H+)
Workup
- customThe solvents were removed in vacuo
Sources & evidence
- ORD record
- ord-b5bf0f45e33040a9a68589d96c8c7615
- Source dataset
- uspto-grants-2010_12
- Patent number
- US07858624B2
Reaction notes
Loading…